Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 9 of 9 for “"Hormone Receptor-Positive"”.
-
Racial Differences in Distress Symptoms Among Black and White Women with Hormone Receptor-Positive Breast Cancer on Adjuvant Endocrine Therapy
… racial disparities among women with early-stage hormone receptor-positive (HR+) breast cancer. By examining the psychological and psychosocial impacts of breast cancer across different stages of the disease trajectory, this research seeks to identify key predictors of distress and develop …
-
Decoding The Tumor and Immune Microenvironment In Pdac and Breast Cancer By Single Cell Sequencing.
… radiotherapy in inducing an immune response in hormone receptor positive breast tumors.</p>
-
Lifetime Occupational Exposure to Endocrine-disrupting Chemicals and Postmenopausal Breast Cancer Risk: A Montreal-based Case-control Study (2008-2011)
… Secondary analyses determined associations by hormone receptor subtype. Methods: Data from a Montreal-based case-control study (2008-2011) among postmenopausal women was used. Breast cancer cases (n=661) were frequency-matched to population-based controls (n=587) by age. Lifetime occupational …
-
The role of orphan nuclear receptor DAX-1 (NR0B1) in human breast cancer cells: expression, proliferation and metastasis
<p>The orphan nuclear hormone receptor DAX-1 (Dosage Sensitive Sex Reversal, Adrenal Hypoplasia Congenita on the X Chromosome, gene 1) plays an important role in the development of adrenal and gonadal tissues and functions as a global negative-regulator of steroidogenesis. In addition, it is known …
-
OTULIN's Novel Regulatory Mechanisms in Genotoxic and Inflammatory NF-kB Signaling
… (TNBC) is aggressive but cannot be treated with hormone therapy or molecular therapy due to the lack of a target. Chemotherapy is a systemic treatment that works by attacking rapidly growing cells, which is initially more effective for TNBC patients than those individuals with the hormone …
-
Identification of therapeutic targets to revert tamoxifen resistance by quantitative proteomic analysis of signaling networks
… biggest problem in endocrine treatment against hormone receptor positive breast cancer patients. HER2 is a membrane receptor tyrosine kinase that is known to correlate with poor disease outcome and unresponsiveness to endocrine treatment. Although much work has been done over the past decades to …
-
Disparities in breast cancer subtype, staging, and access to mammography services in the Lower Mississippi Delta Region
… in the Delta Region had higher rates of hormone receptor-negative breast cancers and higher rates of breast cancer overall compared to white women in the Region. Further, there were no particularly notable differences in late-stage breast cancers between the Delta and non-Delta Regions. …
-
Intrinsic subtypes and prognostic implications in epithelial ovarian cancer
… luminal A breast cancer subtype characterizes hormone receptor positive breast cancer. In study IV, we therefore outlined the protein expression of estrogen receptor (ER) α, ERβ, the progesterone receptor (PR), and the androgen receptor (AR) as well as the prognostic effect of receptor …
-
Treatment outcomes of Her-2 positive Breast Cancer in the absence of Her-2 targeting agents at Groote Schuur Hospital, Cape Town, South Africa. Are we doing enough?
… overall survival of women with early-stage Her-2 positive breast cancer. However, at Groote Schuur Hospital anti-Her-2 targeted treatment is not available. We have therefore evaluated to what extent our patients may be disadvantaged. The primary aims of this study were to evaluate the 3 and 5-year …